Hepatitis B prevalence and treatment needs among Tibetan refugees residing in India
- 8 February 2016
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 88 (8) , 1357-1363
Abstract
Untreated chronic hepatitis B can lead to liver failure and/or liver cancer. These complications can be avoided through prevention with vaccination or treatment of disease. To inform health policy for the Tibetan community in India, we conducted study of hepatitis B prevalence and treatment needs.We conducted a cross-sectional study over three months of 2013. Households were randomly selected for participation via a satellite map; one boarding school and one residential monastery were also included. Participants were asked questions and a whole blood sample was collected for HBsAg assay. Participants with a positive HBsAg result were tested for hepatitis B e antigen, ALT, and AST. Participants with a negative HBsAg result were tested for anti-hepatitis B core antibodies.We recruited 2,769 participants; of which 247 (8.9%) were positive for HBsAg. Participants more likely to have a positive HBsAg result were those born in Tibet (12.4%) and aged 30 to 59 years old. Of those with a positive HBsAg result, 60.7% were positive for hepatitis B e antigen 7% of whom fit into a likely treatment-needed category; the others fit into management categories requiring repeat ALT testing with or without liver fibrosis assessment. Among participants negative for HBsAg, 52.9% from household sampling had anti-HBc antibodies.We identified a high endemicity of chronic hepatitis B in a Tibetan community in India. Resource appropriate approaches are needed for managing chronic hepatitis B in settings such as this one. This article is protected by copyright. All rights reserved.Keywords
Funding Information
- Johns Hopkins University Center for Global Health
This publication has 19 references indexed in Scilit:
- Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional studyThe Lancet Infectious Diseases, 2016
- An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programsIndian Journal of Public Health, 2013
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infectionJournal of Hepatology, 2012
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateHepatology International, 2012
- Calculating prevalence of hepatitis B in India: Using population weights to look for publication bias in conventional meta-analysisIndian Journal of Pediatrics, 2009
- Hepatitis B Virus InfectionNew England Journal of Medicine, 2008
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Clinical implications of HIV and hepatitis B co-infection in Asia and AfricaThe Lancet Infectious Diseases, 2007
- Chronic hepatitis BHepatology, 2007
- Alarming Levels of Hepatitis B Virus Detected among Rural TibetansTropical Doctor, 2004